for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Pfizer raises full-year sales forecast for COVID-19 vaccine

May 4 (Reuters) - Pfizer Inc on Tuesday raised its forecast for full-year sales of the COVID-19 vaccine it co-developed with Germany’s BioNTech SE, as a vaccination drive across the globe intensifies.

The U.S. drugmaker now expects full-year sales of $26 billion from the vaccine, up from its prior forecast of about $15 billion. (Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up